Why the study?
Does the use of drug-eluting stents compared to bare-metal stents affect major adverse cardiovascular and cerebrovascular events or bleeding in patients on long-term warfarin treatment?
Population
415 consecutive patients on long-term warfarin treatment who underwent stenting
Comparison
Drug-eluting stents with triple antithrombotic… vs Bare-metal stents with triple antithrombotic…
Design
Cohort
Follow-up
median 3.5 years
Authors
Loading...
Comparable MACCE rates with DES versus BMS in warfarin patients should not yet change practice; leaves open need for randomized confirmation.
Does the use of drug-eluting stents compared to bare-metal stents affect major adverse cardiovascular and cerebrovascular events or bleeding in patients on long-term warfarin treatment?
In patients on long-term warfarin, drug-eluting stents with short triple therapy showed similar long-term rates of MACCE and major bleeding compared to bare-metal stents.
Annala et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: